| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.65B | 80.69B | 56.45B | 44.21B | 31.65B | 21.94B |
| Gross Profit | 21.96B | 36.67B | 15.08B | 13.05B | 10.25B | 7.87B |
| EBITDA | 9.94B | 12.87B | 8.22B | 8.89B | 6.78B | 5.34B |
| Net Income | 2.40B | 3.84B | 1.95B | 3.04B | 2.48B | 1.63B |
Balance Sheet | ||||||
| Total Assets | 82.66B | 89.78B | 71.16B | 47.06B | 38.07B | 26.75B |
| Cash, Cash Equivalents and Short-Term Investments | 1.90B | 1.94B | 981.40M | 641.50M | 273.30M | 297.10M |
| Total Debt | 33.11B | 36.23B | 23.66B | 17.55B | 12.40B | 8.00B |
| Total Liabilities | 52.36B | 57.14B | 42.60B | 29.54B | 23.69B | 15.39B |
| Stockholders Equity | 30.30B | 32.64B | 28.57B | 16.58B | 13.77B | 11.36B |
Cash Flow | ||||||
| Free Cash Flow | -6.95B | -6.67B | -7.08B | -1.16B | 2.62B | 1.14B |
| Operating Cash Flow | -1.26B | 5.22B | 2.83B | 5.13B | 6.08B | 3.27B |
| Investing Cash Flow | -5.69B | -13.13B | -16.68B | -6.26B | -7.08B | -2.09B |
| Financing Cash Flow | 7.38B | 8.27B | 13.93B | 1.48B | 730.40M | -1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹175.42B | 16.92 | ― | 1.77% | 10.62% | 8.43% | |
69 Neutral | ₹123.72B | 39.41 | ― | 0.23% | 17.23% | 5.49% | |
64 Neutral | ₹156.35B | 66.34 | ― | 0.46% | 15.95% | 8.87% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ₹128.06B | 14.02 | ― | 0.77% | 18.61% | 47.83% | |
57 Neutral | ₹152.27B | 55.68 | ― | 0.15% | 11.26% | 8.37% | |
56 Neutral | ₹204.36B | 42.48 | ― | 0.07% | 41.80% | 91.43% |